Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis
Publisher： John Wiley & Sons Inc
E-ISSN： 1365-2036|41|5|459-466
ISSN： 0269-2813
Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.5, 2015-03, pp. : 459-466
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
